See more : Wavestone SA (WAVE.PA) Income Statement Analysis – Financial Results
Complete financial analysis of VITA 34 AG (V3V.DE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of VITA 34 AG, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- PT Ricky Putra Globalindo Tbk (RICY.JK) Income Statement Analysis – Financial Results
- Chinasoft International Limited (CFTLF) Income Statement Analysis – Financial Results
- Goodwin PLC (GDWN.L) Income Statement Analysis – Financial Results
- THC Therapeutics, Inc. (THCT) Income Statement Analysis – Financial Results
- E for L Aim Public Company Limited (EFORL.BK) Income Statement Analysis – Financial Results
VITA 34 AG (V3V.DE)
About VITA 34 AG
VITA 34 AG engages in the collection, processing, and storage of stem cells from umbilical cord blood and tissue in Germany, Spain, and internationally. It also develops cell therapeutic procedures; cell and gene therapies; cryopreservation of endogenous immune cells; and CAR-T. In addition, the company manufactures advanced therapy medicinal products based on mesenchymal stem cells for experimental treatment by specialized medical institutions; preserves stem cells from perinatal tissue and adult body fat; and engages in the contract manufacturing of pharmaceutical intermediates. VITA 34 AG was founded in 1997 and is based in Leipzig, Germany.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 77.06M | 68.94M | 28.42M | 20.07M | 20.25M | 20.41M | 19.19M | 16.29M | 14.17M | 13.79M | 13.55M | 13.60M | 16.00M | 16.96M | 15.10M | 14.96M | 15.43M | 0.00 |
| Cost of Revenue | 48.82M | 66.21M | 15.98M | 8.41M | 7.63M | 8.44M | 8.39M | 7.67M | 7.68M | 5.91M | 5.49M | 5.56M | 6.54M | 6.14M | 4.96M | 5.15M | 5.03M | -3.48M |
| Gross Profit | 28.24M | 2.74M | 12.44M | 11.66M | 12.61M | 11.98M | 10.80M | 8.62M | 6.49M | 7.88M | 8.06M | 8.04M | 9.46M | 10.82M | 10.14M | 9.81M | 10.39M | 3.48M |
| Gross Profit Ratio | 36.65% | 3.97% | 43.76% | 58.11% | 62.30% | 58.67% | 56.26% | 52.92% | 45.79% | 57.12% | 59.49% | 59.13% | 59.13% | 63.80% | 67.16% | 65.57% | 67.38% | 0.00% |
| Research & Development | 4.31M | 3.44M | 811.00K | 504.00K | 486.00K | 470.00K | 400.00K | 1.20M | 0.00 | 69.00K | 155.00K | 429.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -31.00K |
| General & Administrative | 5.13M | 5.76M | 5.71M | 2.28M | 2.05M | 2.18M | 1.98M | 1.51M | 1.29M | 714.00K | 537.00K | 679.00K | 2.93M | 3.05M | 2.76M | 2.94M | 2.82M | 0.00 |
| Selling & Marketing | 8.39M | 8.27M | 3.67M | 2.75M | 2.77M | 2.97M | 3.43M | 3.13M | 3.14M | 2.80M | 2.78M | 3.51M | 6.97M | 7.24M | 7.63M | 9.64M | 8.43M | -5.34M |
| SG&A | 13.52M | 14.02M | 9.38M | 5.03M | 4.81M | 5.15M | 5.41M | 4.64M | 4.42M | 3.51M | 3.31M | 4.18M | 9.90M | 10.29M | 10.39M | 12.58M | 11.25M | -5.34M |
| Other Expenses | 13.53M | 11.26M | 5.32M | 4.26M | 4.52M | 4.19M | 5.25M | 3.20M | 3.57M | 2.85M | 3.13M | 4.17M | -102.00K | -209.00K | -415.00K | -497.00K | -19.00K | 0.00 |
| Operating Expenses | 31.36M | 28.73M | 15.51M | 9.28M | 9.33M | 9.34M | 10.67M | 7.84M | 7.99M | 6.42M | 6.59M | 8.79M | 9.80M | 10.08M | 9.98M | 12.08M | 11.23M | -5.37M |
| Cost & Expenses | 80.18M | 94.93M | 31.49M | 17.69M | 16.97M | 17.78M | 19.06M | 15.51M | 15.67M | 12.33M | 12.09M | 14.35M | 16.34M | 16.22M | 14.94M | 17.23M | 16.26M | -8.85M |
| Interest Income | 724.00K | 1.12M | 174.00K | 73.00K | 71.00K | 44.00K | 33.00K | 91.00K | 100.00K | 103.00K | 79.00K | 91.00K | 96.00K | 208.00K | 661.00K | 469.00K | 541.00K | 192.00K |
| Interest Expense | 1.73M | 2.05M | 547.00K | 182.00K | 183.00K | 213.00K | 134.00K | 55.00K | 44.00K | 30.00K | 139.00K | 148.00K | 257.00K | 285.00K | 165.00K | 576.00K | 1.84M | 218.00K |
| Depreciation & Amortization | 8.56M | 8.55M | 3.83M | 2.96M | 2.98M | 2.09M | 1.71M | 1.51M | 2.28M | 1.09M | 1.19M | 1.16M | 973.00K | 944.00K | 577.00K | 444.00K | 404.00K | 300.00K |
| EBITDA | 5.81M | -18.34M | 949.00K | 5.01M | 5.48M | 4.12M | 1.89M | 2.36M | 136.00K | 2.22M | 2.66M | 414.00K | 638.00K | 1.90M | 1.40M | -1.71M | 113.00K | 988.00K |
| EBITDA Ratio | 7.53% | -23.66% | 3.39% | 26.99% | 28.71% | 23.19% | 8.67% | 13.97% | 27.73% | 18.67% | 19.71% | 3.30% | 4.59% | 11.17% | 9.27% | -9.07% | 0.73% | 0.00% |
| Operating Income | -3.12M | -25.99M | -2.92M | 2.38M | 3.28M | 2.63M | 135.00K | 780.00K | 1.61M | 1.69M | 1.47M | -742.00K | -335.00K | 743.00K | 162.00K | -2.27M | -832.00K | 8.85M |
| Operating Income Ratio | -4.05% | -37.71% | -10.28% | 11.86% | 16.21% | 12.89% | 0.70% | 4.79% | 11.38% | 12.26% | 10.84% | -5.45% | -2.09% | 4.38% | 1.07% | -15.18% | -5.39% | 0.00% |
| Total Other Income/Expenses | -1.22M | -1.01M | -376.00K | -111.00K | -140.00K | -847.00K | -289.00K | -93.00K | -26.00K | 7.00K | -126.00K | -113.00K | -161.00K | -77.00K | 496.00K | -107.00K | -1.30M | -26.00K |
| Income Before Tax | -4.34M | -28.29M | -3.45M | 2.27M | 3.14M | 1.78M | -153.00K | 687.00K | 1.59M | 1.70M | 1.34M | -855.00K | -496.00K | 666.00K | 658.00K | -2.38M | -2.13M | 0.00 |
| Income Before Tax Ratio | -5.63% | -41.04% | -12.13% | 11.31% | 15.52% | 8.74% | -0.80% | 4.22% | 11.20% | 12.31% | 9.91% | -6.29% | -3.10% | 3.93% | 4.36% | -15.89% | -13.82% | 0.00% |
| Income Tax Expense | -2.31M | -908.00K | 479.00K | 769.00K | 1.80M | 952.00K | 172.00K | 71.00K | -115.00K | 707.00K | 555.00K | -246.00K | -1.69M | 317.00K | 62.00K | -417.00K | 98.00K | 0.00 |
| Net Income | -1.87M | -27.39M | -3.93M | 1.45M | 1.35M | 828.00K | -322.00K | 408.00K | 1.98M | 1.10M | 838.00K | -579.00K | 1.19M | 349.00K | 596.00K | -1.71M | -1.19M | 0.00 |
| Net Income Ratio | -2.42% | -39.72% | -13.82% | 7.22% | 6.67% | 4.06% | -1.68% | 2.50% | 13.97% | 7.98% | 6.18% | -4.26% | 7.44% | 2.06% | 3.95% | -11.45% | -7.68% | 0.00% |
| EPS | -0.12 | -1.73 | -0.67 | 0.35 | 0.33 | 0.20 | -0.09 | 0.14 | 0.65 | 0.35 | 0.27 | -0.20 | 0.47 | 0.18 | 0.22 | -0.63 | -0.46 | 0.00 |
| EPS Diluted | -0.12 | -1.73 | -0.67 | 0.35 | 0.33 | 0.20 | -0.09 | 0.14 | 0.65 | 0.35 | 0.27 | -0.20 | 0.47 | 0.18 | 0.22 | -0.63 | -0.46 | 0.00 |
| Weighted Avg Shares Out | 15.88M | 15.83M | 5.83M | 4.10M | 4.10M | 4.08M | 3.55M | 2.96M | 2.96M | 3.12M | 3.03M | 2.84M | 2.72M | 2.72M | 2.72M | 2.73M | 2.57M | 2.11M |
| Weighted Avg Shares Out (Dil) | 15.88M | 15.83M | 5.83M | 4.10M | 4.10M | 4.08M | 3.55M | 3.05M | 3.04M | 3.12M | 3.11M | 2.92M | 2.72M | 2.72M | 2.72M | 2.73M | 2.57M | 2.11M |
Source: https://incomestatements.info
Category: Stock Reports